Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Fungal Group Zygomycota

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis?

mBio·2022

Same author

Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2022

Same author

Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey - a closer look at an immunocompromised cancer patient population.

The Journal of infection·2022

Same author

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis.

Frontiers in immunology·2022

Same author

Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model.

mSphere·2022

Same author

Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata.

Microbiology spectrum·2022

Search research articles

Related Experiment Video

Updated: May 26, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Pulmonary mucormycosis.

Georgios Hamilos¹, George Samonis, Dimitrios P Kontoyiannis

¹Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece.

Seminars in Respiratory and Critical Care Medicine

|December 15, 2011

Summary

This summary is machine-generated.

Mucormycosis is a dangerous fungal infection affecting immunocompromised individuals. Early diagnosis and treatment, including antifungals and surgery, are crucial for survival.

More Related Videos

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Area of Science:

Mycology
Infectious Diseases
Immunology

Background:

Mucormycosis is a life-threatening opportunistic fungal infection.
It primarily affects immunocompromised individuals, including those with neutropenia, corticosteroid use, diabetes, and iron overload.
Emerging as a breakthrough sinopulmonary infection in transplant and hematologic patients, often during antifungal prophylaxis for Aspergillus.

Purpose of the Study:

To highlight the challenges in diagnosing and treating pulmonary mucormycosis.
To discuss the limited efficacy of current antifungals against Mucorales.
To explore novel therapeutic strategies targeting iron metabolism and fungal-endothelial interactions.

Main Methods:

Review of current literature on mucormycosis pathogenesis and treatment.
Analysis of clinical outcomes and diagnostic challenges.
Investigation into the role of iron metabolism and host-pathogen interactions.

Main Results:

Prognosis for pulmonary mucormycosis has not significantly improved.
Difficulties in early diagnosis and limited antifungal activity against Mucorales are major hurdles.
Iron metabolism and fungal-endothelial interactions are key to pathogenesis.

Conclusions:

Prompt antifungal therapy, preferably with lipid amphotericin B, is essential.
Reversing underlying host factors is critical for patient survival.
Aggressive surgical intervention offers the best chance for managing this devastating mycosis.